Headache News and Research

Latest Headache News and Research

Factors that increase the possibility of having migraines

A migraine is the most common type of headache that propels patients to seek care from their doctors. Roughly 30 million Americans suffer from migraine headaches, with women affected almost three times more often than men, according to statistics from the National Headache Foundation in Chicago.

21 Mar 2012

IDSA releases new rhinosinusitis guidelines

The vast majority of sinus infections are caused by viruses and should not be treated with antibiotics, suggest new guidelines released by the Infectious Diseases Society of America.

21 Mar 2012

Noven completes LDMP Phase 3 studies on menopausal VMS

Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that it has completed the Phase 3 clinical development program evaluating low-dose mesylate salt of paroxetine (LDMP) for the treatment of vasomotor symptoms (VMS) associated with menopause.

21 Mar 2012

Novartis' Arcapta Neohaler now available in the U.S. for COPD treatment

Novartis Pharmaceuticals Corporation today announced that once-daily Arcapta Neohaler (indacaterol inhalation powder) 75 mcg is now available in the US and in pharmacies nationwide.

20 Mar 2012

GOP plans for Medicare, health reform repeal draw scrutiny

Political observers are noting challenges for Republican lawmakers in upcoming budget, health law and Medicare debates.

19 Mar 2012

Allergy-free egg in the making

Researchers at CSIRO and experts at Geelong's Deakin University have found a way to “switch off” four egg allergens. These modified eggs could produce chickens that lay hypoallergenic eggs but the genes and DNA of the chicken would remain unaltered.

15 Mar 2012

Many people do not recognize stroke symptoms

Nationwide ambulance use by patients suffering from a stroke has not changed since the mid-1990s, even though effective stroke treatments are now available.

15 Mar 2012

Bayer HealthCare receives FDA approval for Natazia to treat HMB

Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new indication for Natazia (estradiol valerate and estradiol valerate/dienogest) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus (womb), in women who choose an oral contraceptive (OC) for contraception.

15 Mar 2012

Researchers identify variation in head CT use among ED doctors

A new study by Brigham and Women's Hospital (BWH) researchers found significant variation in the use of head computed tomography (CT) exams among doctors within the emergency department.

13 Mar 2012

Study reveals significant variation in use of head computed tomography

Imaging has been identified as one of the key drivers of increased healthcare costs. A new study from Brigham and Women's Hospital and Harvard Medical School has found significant variation in the use of head computed tomography (CT), even within a single emergency department. Strategies to reduce such variation in head CT use may reduce cost and improve quality of care.

12 Mar 2012

Pfizer’s Prevnar 13 Phase 3 study for pneumococcal disease meets all study endpoints

Pfizer Inc. announced today that data from a Phase 3 study of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) met all study endpoints, showing immunogenicity and establishing a safety profile in children and adolescents aged 5 through 17 years.

12 Mar 2012

New study finds significant variation in head CT use

9 Mar 2012

FDA approves Teva's ProAir HFA with dose counter for asthma, COPD and EIB

Teva Respiratory announced today that the U.S. Food and Drug Administration (FDA) has approved ProAir HFA with a dose counter for use in patients 4 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.

8 Mar 2012

Lilly, Boehringer Ingelheim announce availability of Jentadueto tablets

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced Jentadueto (linagliptin/metformin hydrochloride) tablets are now available by prescription in many leading chain and independent pharmacies across the U.S.

8 Mar 2012

Mild TBI may increase risk of postconcussive symptoms in children

Children who experience mild traumatic brain injury may be more likely to show increases in symptoms over time that could impact quality of life, more so than children who experience an orthopedic injury. Injury severity could play a role.

7 Mar 2012

Concussion in kids may lead to memory and cognitive problems at school later in life

The researchers from Nationwide Children’s Hospital and The Ohio State University looked at 186 children aged 8 to 15 who experienced concussion - most commonly in a fall or while playing sports - or other brain injury from a car accident or other causes. The children’s parents were asked to fill out a standard questionnaire to assess their child’s cognitive and physical status before the concussion, and again two weeks, three months and a year later. These responses were compared to those from parents of 99 similar children who came into the emergency room with orthopedic injuries.

7 Mar 2012

Persistent postconcussion symptoms more likely in children with TBIs

Children with mild traumatic brain injuries appear more likely to have persistent postconcussion symptoms, including cognitive complaints such as inattention and forgetfulness, which can affect quality of life, according to a report published Online First by Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

6 Mar 2012